Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 57%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc. is experiencing substantial growth, evidenced by a 53.3% increase in revenue and a 23-point expansion in adjusted operating margins year-over-year, highlighting the effectiveness of its strategic initiatives. The company projects an adjusted operating income margin of approximately 22.4% for the fourth quarter of 2025, indicating operational efficiency improvements tied to investments in marketing strategies and new programming. Furthermore, Hinge Health's current penetration rate of eligible clients is significantly lower than traditional physical therapy, suggesting considerable growth opportunities as it enhances tools like Hinge Connect to drive higher yields and member engagement.

Bears say

Hinge Health Inc. is experiencing a concerning decline in adjusted research and development expenses as a percentage of revenue, dropping from 23.7% in 3Q24 to 14.5% in 3Q25, which raises questions about future innovation and competitiveness. Additionally, management's guidance indicating a shift to mid-teens EBIT margins in the second half of 2025 suggests a deterioration in profitability, with FY26 and FY27 expectations remaining low at 14.6% and 16.2%, respectively. Furthermore, the anticipated sequential decline in membership in 4Q25, combined with reduced marketing spending due to expected lower ROI during holiday seasonality, casts further doubt on the company’s ability to sustain growth momentum.

HNGE has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 57% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 14 analysts, HNGE has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $60.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $60.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.